Ascendis Pharma (ASND) Earnings
|
Expand Research on ASND
| Next EPS Date | 8/6/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -109.6% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +3.9% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/6/26  |
Q226 | N/A | EUR1.57 | N/A | N/A | EUR329.94M | N/A | N/A | N/A | ||
| 5/7/26 | Q126 | EUR0.27 | EUR0.18 | +EUR0.09 | EUR246.6M | EUR269.95M | N/A |  | | Details | |
| 5/4/26 |
Q126 | N/A | EUR0.18 | N/A | N/A | EUR269.95M | N/A | N/A | N/A | ||
| 5/1/26 |
Q126 | N/A | EUR0.18 | N/A | N/A | EUR269.95M | N/A | N/A | N/A | ||
| 4/30/26 |
Q126 | N/A | EUR0.18 | N/A | N/A | EUR269.95M | N/A | N/A | N/A | ||
| 2/11/26 | Q425 | -EUR0.55 | -EUR0.15 | -EUR0.40 | EUR240M | EUR245.68M | N/A | | | Details | |
| 11/12/25 | Q325 | -EUR1.00 | -EUR0.28 | -EUR0.72 | EUR213.63M | EUR213.17M | N/A | | | Details | |
| 8/7/25 | Q225 | -EUR0.82 | -EUR1.27 | +EUR0.45 | EUR158.05M | EUR142.38M | N/A | | | Details |
